CME Planet
  • $0.00
  • Activities
    Topics
    • Acute Coronary Syndromes
    • Arrhythmia
    • Cardiometabolic Risk
    • Transthyretin Amyloid Polyneuropathy
    • Chronic Kidney Disease
    • Diabetes
    • Dyslipidemia
    • Heart Failure
    • Hypertension
    • Interventional Cardiology
    • Ischemic Heart Disease
    • Narcolepsy & OSA
    • Nephrology
    • Opiod Induced Constipation
    • Stroke
    • Hyperkalemia
    Target Audience
    • Cardiologists
    • Other Healthcare Professionals
    • Sleep Center Managers
    • Sleep Technologists
    • Nephrologist
    Credit Type
    • CE
    • CME
    Media Type
    • Audio
    • External Link
    • PDF
    • Video
  • Resources
    • News
    • Guidelines
    • Clinical Trials
    • Press Releases
  • Calendar
  • About Us
  • Contact Us
  • Log In / 
  • No Account? Register free
  • Home
  • Member
  • Login

21419_Unmasking Narcolepsy: Diagnostic and Therapeutic Strategies

Michael Thorpy, MD (Chair) and Allen Boone, RPSGT, RST, CCRC discussion of diagnosis, testing, treatment options and associated clinical efficacy and safety data in narcolepsy management.

The American Academy of Sleep Medicine (AASM) documents that more than 70 million people in the US have sleep disorders, most of whom are unaware of it. Currently, there are over 80 recognized sleep disorders, including narcolepsy. The diagnosis of narcolepsy is often overlooked and could be attributed to other medical or even psychiatric conditions with years of missed diagnosis. Sleep technologists can aid in the diagnosis of patients with narcolepsy and truly help narcoleptics lead better and healthier lives.

Narcolepsy is a disorder of the central nervous system that is described as a syndrome consisting of excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hallucinations, automatic behaviors, and fragmented or disrupted sleep. If left untreated, narcoleptics risk falling asleep any time during the day, emphasizing the importance of controlling the condition for individuals who regularly operate dangerous machinery or rely on motor vehicles for regular transportation. Furthermore, the increased risk of injury (falls or trauma), along with the intermittent nature of this disabling neurological condition, often leads to significant psychosocial impairment. Unfortunately, lifestyle changes are rarely sufficient to adequately control the symptoms of narcolepsy. Therefore, most patients require life-long medication to cope with the debilitating effects of the disorder. Since no cure for narcolepsy exists, non-pharmacologic and symptom directed pharmacologic treatments are used together for optimal management of patients.

Experts in narcolepsy management will describe best practices in diagnosis including definitions from (DSM-5) and the new (ICSD-3) guidelines, the latest diagnostic tests available to detect narcolepsy, treatment options and associated clinical efficacy and safety data.

Login to your Account


No Account Yet? Register Here!

Forgot your password?

or

Login or Register with

Sign in with twitter
Sign in with google


Activity Categories

  • Topics
    • Acute Coronary Syndromes ( 9 )
    • Arrhythmia ( 1 )
    • Cardiometabolic Risk ( 13 )
    • Transthyretin Amyloid Polyneuropathy ( 1 )
    • Chronic Kidney Disease ( 2 )
    • Diabetes ( 7 )
    • Dyslipidemia ( 8 )
    • Heart Failure ( 14 )
    • Hypertension ( 1 )
    • Interventional Cardiology ( 9 )
    • Ischemic Heart Disease ( 3 )
    • Narcolepsy & OSA ( 15 )
    • Nephrology ( 1 )
    • Opiod Induced Constipation ( 1 )
    • Stroke ( 5 )
    • Hyperkalemia ( 1 )
  • Target Audience
    • Cardiologists (5)
    • Other Healthcare Professionals (5)
    • Sleep Center Managers (5)
    • Sleep Technologists (5)
    • Nephrologist (5)
  • Credit Type
    • CE (2)
    • CME (2)
  • Media Type
    • Audio (4)
    • External Link (4)
    • PDF (4)
    • Video (4)

Future Live Events

2026 American Association of Heart Failure Nurses (AAHFN)
Jun 24, 2026

(2026 AAHFN) Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care
Jun 24, 2026

(2026 AAHFN) New Opportunities with Mineralocorticoid Receptor Antagonists to Improve Outcomes in Heart Failure
Jun 25, 2026

(2026 AAHFN) Practical Management of Transthyretin Cardiac Amyloidosis
Jun 25, 2026

2026 San Diego Heart Failure Summer Symposium (SDHF)
Jul 09, 2026

2026 Heart Failure Management (HFM)
Jul 16, 2026

2026 American Academy of Family Physicians FMX (AAFP)
Oct 20, 2026

Sign Up For Our Newsletter

About

CMEPlanet.com is owned and operated by Voxmedia International.

Voxmedia LLC is an ACCME-accredited provider offering independent medical education services spanning graphic design, web and print production, logistical services, and scientific content development. Voxmedia produces CME symposia, live meetings, and multimedia educational products.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Site Navigation

  • Activities
  • News
  • Calendar
  • About Us
  • Contact Us

Information

  • About us
  • Privacy Policy
  • Cookies Policy
  • Consent Preferences
  • Terms and Conditions

Newsletter

Sign up to our newsletter!

© 2026  CMEPlanet. All Rights Reserved.

Site development by Developed by Hop Studios, Vancouver Web design and development shop Hop Studios

Log In

New Customer?

Create an Account